Search results
Has Novavax Just Solved Its Biggest Problem?
Motley Fool via Yahoo Finance· 2 months agoMany investors have seen Novavax (NASDAQ: NVAX) as a promising recovery story ever since the biotech launched a plan to cut costs to better match the...
Is This the Telltale Sign to Sell Novavax Stock?
Motley Fool· 1 year agoUnfortunately, Novavax (NASDAQ: NVAX) hasn't had great timing. The company was late to the party in winning authorizations for its COVID-19 vaccine,...
Is Novavax a Buy Now?
Motley Fool via Yahoo Finance· 2 months agoNovavax (NASDAQ: NVAX) has taken investors on a roller coaster ride over the past week or so. The stock soared after the company settled a dispute with a...
Is There Any Hope for Novavax?
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) has brought investors extreme gains and extreme losses in just a few years. Since, Novavax shares have made their way...
Novavax Just Dropped a Bombshell on Investors: Even Management Is Questioning Its Future
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) faces an uncertain future ahead as the need for COVID-19 vaccines diminishes....
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
Zacks via Yahoo Finance· 5 months agoNovavax NVAX announced that the World Health Organization (“WHO”) has granted emergency use listing...
Novavax COVID vaccine, new 4th option, approved by FDA
NY Daily News via AOL· 2 years agoAmericans will soon have a fourth COVID vaccine option. Novavax’s more traditional vaccine was...
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) has offered investors just such a ride over the past few years. Initial gains...
Is This a Good Sign for Novavax?
Motley Fool· 10 months agoNovavax (NASDAQ: NVAX) shares soared more than 30% in one trading session this week. The biotech stock has been in the doldrums ever since the company...
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...